These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 435771)

  • 41. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care.
    Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J;
    J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colonic distention at CT colonography: randomized evaluation of both IV hyoscine butylbromide and automated carbon dioxide insufflation.
    Nagata K; Fujiwara M; Shimamoto T; Iida N; Mogi T; Mitsushima T
    AJR Am J Roentgenol; 2015 Jan; 204(1):76-82. PubMed ID: 25539240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of hyoscine butylbromide on the swallowing of capsules.
    Channer KS; Wolinski A; Kaye B; Virjee J
    Br J Clin Pharmacol; 1983 May; 15(5):560-3. PubMed ID: 6860531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evidence for using hyoscine N-butylbromide (Buscopan) in ureteric obstruction.
    Bourdoumis A; Stasinou T; Papadopoulos G; Buchholz N
    Int J Clin Pract; 2014 Sep; 68(9):1174. PubMed ID: 25196183
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of hyoscine-N-butylbromide on exocrine pancreatic secretion.
    Odes HS; Helman CA; Barbezat GO; Bank S
    S Afr Med J; 1977 Jul; 52(1):17-9. PubMed ID: 888038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of imecromone and hyoscine N-butylbromide in endoscopic cholangiopancreatography].
    Garbarini A; Foco A; Serenthà U; Enrichens F; Mao P; Rossetti F
    Minerva Chir; 1986 Jan; 41(1-2):45-50. PubMed ID: 3703309
    [No Abstract]   [Full Text] [Related]  

  • 47. The value of hyoscine butylbromide in aorto-iliac intravenous digital subtraction angiography.
    Bennett C; Phillips GW; Colthurst JR; Lea Thomas M
    Vasa; 1987; 16(3):262-4. PubMed ID: 3310446
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of diazepam and hyoscine butylbromide on response to secretin and cholecystokinin-pancreozymin in man.
    Saunders JH; Masoero G; Wormsley KG
    Gut; 1976 May; 17(5):351-3. PubMed ID: 1278718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are anticholinergics of use in the irritable colon syndrome?
    Ivey KJ
    Gastroenterology; 1975 May; 68(5 Pt 1):1300-7. PubMed ID: 1092588
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study of a new synthetic spasmolytic (DA 3177) in emergency medicine].
    Del Fabbro L; Di Bartolomeo C; Grassi L; Lestuzzi A; Perraro F; Tosolini G
    Clin Ter; 1977 Dec; 83(6):609-23. PubMed ID: 343975
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The muscle relaxant action of scopolamine butylbromide (buscopan)].
    PHILIPPOT E; DALLEMAGNE MJ
    Arch Int Pharmacodyn Ther; 1953 Apr; 93(3-4):337-40. PubMed ID: 13066127
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyoscine-N-butylbromide (Buscopan) as a duodenal relaxant in tubeless duodenography.
    Ayre-Smith G
    Acta Radiol Diagn (Stockh); 1976 Sep; 17(5B):701-13. PubMed ID: 790897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacological and clinical observations on the combination of scopolamine N-butylbromide and aminopyrine sodium sulfonate (buscopan compositum)].
    MARINO A; MURARO U
    Rass Int Clin Ter; 1959 Dec; 39():1247-93 contd. PubMed ID: 14421165
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
    Ujiie H; Shimizu T; Natsuga K; Arita K; Tomizawa K; Shimizu H
    Clin Exp Dermatol; 2006 Jul; 31(4):588-9. PubMed ID: 16716168
    [No Abstract]   [Full Text] [Related]  

  • 56. Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial.
    Dobrilla G; Imbimbo BP; Piazzi L; Bensi G
    Gut; 1990 Mar; 31(3):355-8. PubMed ID: 2182401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experience with an approved morphine-saving spasmo-analgetic].
    Pfannemüller M
    ZFA (Stuttgart); 1977 Jul; 53(19):1128-31. PubMed ID: 888548
    [No Abstract]   [Full Text] [Related]  

  • 58. Some effects of injected hyoscine butylbromide: a versatile class experiment in human pharmacology.
    Herxheimer A; de Groot AC
    Br J Clin Pharmacol; 1977 Jun; 4(3):337-42. PubMed ID: 901701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Scopolamine butylbromide (0.2 mg.kg-1) prevents succinylcholine-induced bradycardia in infants and children].
    Tsuji MH; Yamashita M
    Masui; 1992 Apr; 41(4):670-2. PubMed ID: 1578626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Combined administration of metoclopramide, scopolan and proacid in the treatment of chronic duodenal ulcer].
    Tkaczewski W; Chojnacki J; Dziekański S; Szeszko A
    Wiad Lek; 1978 Jan; 31(1):11-3. PubMed ID: 654252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.